This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Centre International De Recherches Dermatologiques Galderma, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 1988-1998.
Company Filing History:
1 out of 44 
1 out of 5,383 
1 out of 1,853 
Years Active: 1988-1998
Title: The Innovative Contributions of Alain Doutheau
Introduction
Alain Doutheau is a notable inventor based in Lyons, France. He has made significant contributions to the field of dermatological research and anti-tumor medicine. With a total of 2 patents, his work has had a considerable impact on the scientific community.
Latest Patents
Doutheau's latest patents include groundbreaking research on apoptosis-modulating factors. This research focuses on the modulation of programmed cell death in mammalian organisms, which can be crucial for preventing and combating photoinduced or chronological aging of the skin. The patent details the administration of effective apoptosis-modulating amounts of active species such as methional and malondialdehyde. Another significant patent involves epoxide derivatives, which outlines a method of preparing compounds that can be used as anti-tumor medicines.
Career Highlights
Throughout his career, Alain Doutheau has worked with prestigious organizations such as Galderma and the National Centre for Scientific Research (CNRS). His research has contributed to advancements in dermatology and oncology, showcasing his dedication to improving human health.
Collaborations
Doutheau has collaborated with esteemed colleagues, including Gerard Anthony Quash and Jacques Gore. These partnerships have further enriched his research and innovation efforts.
Conclusion
Alain Doutheau's contributions to science through his patents and collaborations highlight his role as a significant inventor in the field of dermatology and anti-tumor research. His work continues to influence advancements in medical science.